Evidence for efficacy is based on the results from the Beamion LUNG-1 study
Home World News FDA Grants Accelerated Approval to Zongertinib for Unresectable or Metastatic Non-Squamous NSCLC
Evidence for efficacy is based on the results from the Beamion LUNG-1 study
